Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
AQB | US
-0.10
-8.33%
Healthcare
Biotechnology
30/06/2024
21/10/2024
1.10
1.20
1.20
1.10
AquaBounty Technologies Inc. a biotechnology company focuses on enhancing productivity in the commercial aquaculture industry in the United States and Canada. It engages in genetic genomic and fish health and nutrition research activities. The company also operates salmon farms using proprietary technology. It offers AquAdvantage Salmon a bioengineered Atlantic salmon for human consumption; and sells conventional Atlantic salmon salmon eggs fry and byproducts. The company was formerly known as Aqua Bounty Farms Inc. and changed its name to AquaBounty Technologies Inc. in June 2004. AquaBounty Technologies Inc. was incorporated in 1991 and is headquartered in Maynard Massachusetts.
View LessLow Debt to Equity (< 0.25)
Low Debt to Asset (< 0.2)
Value Stock (Price to Book < 3)
Negative Momentum (Declining Price)
Price Below SMA10D
High 6-Month Volatility (>65%)
Microcap (<300M USD)
High Market Beta (> 0.8)
Weak Operating Margin (< 10%)
Declining Revenue (< 0%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
62.5%1 month
83.7%3 months
97.6%6 months
76.3%-
-
0.04
0.10
0.08
0.02
7.45
-
-24.31M
4.25M
4.25M
-
-2.80K
-
-77.10
-53.94
2.41
2.37
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bearish (SMA6M < SMA12M)
Range10D
0.16
Range1M
0.29
Range3M
0.95
Rel. volume
0.98
Price X volume
19.55K
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Azitra Inc | AZTR | Biotechnology | 0.61 | 4.65M | 0.00% | 0.01 | 41.86% |
ADTX | ADTX | Biotechnology | 1.09 | 4.60M | 3.81% | n/a | 122.46% |
Pasithea Therapeutics Corp. Common Stock | KTTA | Biotechnology | 4.39 | 4.59M | 1.62% | n/a | 0.00% |
Hepion Pharmaceuticals Inc | HEPA | Biotechnology | 0.7501 | 4.35M | -8.30% | n/a | 4.33% |
Titan Pharmaceuticals Inc | TTNP | Biotechnology | 4.58 | 4.19M | -4.38% | n/a | 0.00% |
NuCana plc | NCNA | Biotechnology | 1.86 | 4.18M | -1.06% | n/a | 0.00% |
Fresh America Corp | FRES | Biotechnology | 1.66 | 4.07M | -15.74% | n/a | 0.22% |
Lipella Pharmaceuticals Inc. Common Stock | LIPO | Biotechnology | 0.4896 | 3.97M | -0.99% | n/a | 5.50% |
Windtree Therapeutics Inc | WINT | Biotechnology | 1.07 | 3.94M | 17.16% | n/a | 36.99% |
Genprex Inc | GNPX | Biotechnology | 1.51 | 3.91M | 265.62% | n/a | 0.00% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
---|---|---|---|---|---|---|---|
Twin Vee PowerCats Co. Common Stock | VEEE | Recreational Vehicles | 0.4659 | 4.44M | -2.96% | n/a | 19.98% |
Forza X1 Inc | FRZA | Recreational Vehicles | 0.19 | 2.99M | -13.68% | n/a | 0.97% |
EZGO Technologies Ltd. Ordinary Shares | EZGO | Recreational Vehicles | 1.06 | 2.71M | 0.00% | n/a | 17.32% |
Vision Marine Technologies Inc | VMAR | Recreational Vehicles | 3.65 | 2.01M | -6.89% | n/a | 0.00% |
Micromobility.com Inc. | MCOM | Recreational Vehicles | 0.011 | 1.01M | 10.00% | n/a | -37.05% |
Parameter | Company | Industry | Indicator |
---|---|---|---|
Enterprise to EBITDA | 0.02 | 0.53 | Cheaper |
Ent. to Revenue | 7.45 | 3,967.00 | Cheaper |
PE Ratio | - | 41.03 | - |
Price to Book | 0.04 | 15.55 | Cheaper |
Dividend Yield | - | 2.20 | - |
Std. Deviation (3M) | 97.57 | 72.80 | Riskier |
Debt to Equity | 0.10 | -1.23 | Expensive |
Debt to Assets | 0.08 | 0.25 | Cheaper |
Market Cap | 4.25M | 3.66B | Emerging |